These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 31265657)

  • 1. Erratum: The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy: Erratum.
    Medicine (Baltimore); 2016 Oct; 95(42):e18ea. PubMed ID: 31265657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy.
    Tai H; Wang MY; Zhao YP; Li LB; Dong QY; Liu XG; Kuang JS
    Medicine (Baltimore); 2016 Aug; 95(33):e4541. PubMed ID: 27537577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes.
    DeFronzo RA; Burant CF; Fleck P; Wilson C; Mekki Q; Pratley RE
    J Clin Endocrinol Metab; 2012 May; 97(5):1615-22. PubMed ID: 22419732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Medicine, Volume 95, Issue 23: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(28):e0916. PubMed ID: 31265603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Kay S; Strickson A; Puelles J; Selby R; Benson E; Tolley K
    Diabetes Ther; 2017 Apr; 8(2):251-273. PubMed ID: 28275958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alogliptin: a review of its use in patients with type 2 diabetes mellitus.
    Keating GM
    Drugs; 2015 May; 75(7):777-96. PubMed ID: 25855222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-on Therapy to Metformin in Patients with Uncontrolled Type 2 Diabetes Mellitus.
    Gordon J; McEwan P; Hurst M; Puelles J
    Diabetes Ther; 2016 Dec; 7(4):825-845. PubMed ID: 27787778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study.
    DeFronzo RA; Fleck PR; Wilson CA; Mekki Q;
    Diabetes Care; 2008 Dec; 31(12):2315-7. PubMed ID: 18809631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alogliptin benzoate for the treatment of type 2 diabetes.
    Rendell M; Drincic A; Andukuri R
    Expert Opin Pharmacother; 2012 Mar; 13(4):553-63. PubMed ID: 22296609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects.
    Karim A; Covington P; Christopher R; Davenport M; Fleck P; Li X; Wann E; Mekki Q
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):46-58. PubMed ID: 20040339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis.
    Sharma R; Wilkinson L; Vrazic H; Popoff E; Lopes S; Kanters S; Druyts E
    Curr Med Res Opin; 2018 Sep; 34(9):1595-1603. PubMed ID: 29764222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin.
    Al Omari M; Khader Y; Dauod AS; Beni Yonis OA; Khassawneh AH
    J Drug Assess; 2016; 5(1):29-33. PubMed ID: 27994943
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.
    Chen XW; He ZX; Zhou ZW; Yang T; Zhang X; Yang YX; Duan W; Zhou SF
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1225-38. PubMed ID: 26218204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature: Erratum.
    Medicine (Baltimore); 2016 Sep; 95(36):e29d2. PubMed ID: 31265639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The design and baseline characteristics of a phase III study to evaluate the efficacy and safety of alogliptin versus placebo in type 2 diabetes mellitus in Mainland China].
    Pan CY; Li WH; Zeng JE; Li CJ; Yang JK; Ji QH; Lu JM; Lü XF; Li XF; Qu S; Xu XJ; Xue YM; Li L; Jiang ZS; Zheng BZ; Bu RF; Han P; Liu Y; Liu JD; Peng YD; Liu XM; Liu ZM; Yan L; Lei MX; Li XJ; Song QH; Shi BY; Gu W; Li ZF
    Zhonghua Nei Ke Za Zhi; 2013 Nov; 52(11):932-5. PubMed ID: 24439186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sitagliptin compared with sulfonylurea therapy in patients with type 2 diabetes showing inadequately controlled glycosylated hemoglobin with metformin monotherapy: A meta-analysis.
    Hou L; Zhao T; Liu Y; Zhang Y
    Exp Ther Med; 2015 Apr; 9(4):1528-1536. PubMed ID: 25780464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials: Erratum.
    Medicine (Baltimore); 2016 Jul; 95(30):e156a. PubMed ID: 31265613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum.
    Medicine (Baltimore); 2017 Jun; 96(26):e7458. PubMed ID: 31305690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women: Erratum.
    Medicine (Baltimore); 2016 Oct; 95(43):e561e. PubMed ID: 31265662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.